Droxidopa

CAS 23651-95-8

Overview

Droxidopa is used to treat neurogenic orthostatic hypotension (lightheadedness, dizziness, or fainting) caused by primary autonomic failure (eg, Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy

Anant Labs manufacture and furnish high quality Droxidopa impurities for global markets. Our Droxidopa EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Droxidopa

CAS 23651-95-8In Stock

Technical Data

CAS23651-95-8

Mol. FormulaC₉H₁₁NO₅

Mol. Weight213.189 g/mol

IUPAC(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

SMILESC1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O

InChIInChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1

InChI KeyQXWYKJLNLSIPIN-JGVFFNPUSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms

droxidopa23651-95-8L-DOPS(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acidNortheraDOPSthreo-DopaserineL-threo-DOPSL-ThreodopsL-dihydroxyphenylserine